Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis

Journal of Clinical Gastroenterology

Volumn 37, Issue 2, 2003, Pages 183-185

  Siegel, Joanna L ^b   Jorgensen, Roberta ^b   Angulo, Paul ^b   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Primary biliary cirrhosis; Ursodeoxycholic acid; Weight gain

Indexed keywords

PLACEBO; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BODY MASS; CHOLESTASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; OBESITY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; THROMBOCYTOPENIA; VOMITING; WEIGHT GAIN;

BODY MASS INDEX; CHOLAGOGUES AND CHOLERETICS; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; URSODEOXYCHOLIC ACID; WEIGHT GAIN;

EID: 0038044776     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200308000-00018     Document Type: Article

References (22)

1. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 1973;289:674-678.
2. Roll J, Boyer JL, Barry D, et al. The prognostic Importance of Clinical and Histologic Features in Asymptomatic and Symptomatic Primary Biliary Cirrhosis N Engl J Med. 1983;308:1-7.
3. Lanspa SJ, Chan AT, Bell JS 3rd, et al. Pathogenesis of steatorrhea in primary biliary cirrhosis. Hepatology. 1985;5:837-842.
4. Beckett GJ, Dewhurst N, Finlayson ND, et al. Weight loss in primary biliary cirrhosis. Gut. 1980;21:734-737.
5. DiBaise JK, Paustian FF. Steatorrhea and weight loss in a 72-year-old man. Am J Gastroenterol. 1998;93:2226-2230.
6. Zukowski TH, Jorgensen RA, Dickson ER, et al. Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy. Am J Gastroenterol. 1998;93:958-961.
7. Logan RF, Ferguson A, Finlayson ND, et al. Primary biliary cirrhosis and celiac disease, an association? Lancet. 1978;1:230-233.
8. Ginn P, Workman RD. Primary biliary cirrhosis and adult celiac disease. West J Med. 1992;156:547-549.
9. Iliffe GD, Owen DA. An association between primary biliary cirrhosis and jejunal villous atrophy resembling celiac disease. Dig Dis Sci. 1979;24:802-806.
10. Behr W, Barnert J. Adult celiac disease and primary biliary cirrhosis. Am J Gastroenterol. 1986;81:796-799.
11. Madrid AM, Brahm J, Antezana C, et al. Small bowel motor activity in primary biliary cirrhosis. Am J Gastroenterol. 1998;93:2436-2440.
12. Lindor KD, Dickson ER, Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology. 1994;106:1284-1290.
13. Angulo P, Dickson ER, Therneau TM, et al. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. J Hepatol. 1999;30:830-835.
14. Angulo P, Lindor KD, Therneau TM, et al. Utilization of the Mayo Risk Score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver. 1999;19:115-121.
15. Gores GJ. Mechanisms of cell injury and death in cholestasis and hepatoprotection by ursodeoxycholic acid. J Hepatol. 2000;2(Suppl. 2):11-13.
16. Pratt DS, Kaplan MM. Abdominal pain after taking ursodiol. N Engl J Med. 1993;328:1502-1503.
17. Angulo P. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology. 1999;29:644-647.
18. Argiles JM, Lopez-Soriano J, Busquets S, et al. Journey from cachexia to obesity by TNF. FASEB J. 1997;11:743-751.
19. Davis MP, Dickerson D. Cachexia and anorexia. Cancer's Covert Killer. Support Care Cancer. 2000;8:180-187.
20. Langstein HN, Norton JA. Mechanisms of cancer cachexia. Hematol Oncol Clin North Am. 1991;5:103-123.
21. Tilg J, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000;343:1467-1476.
22. Angulo P, Neuman MG, Shear NH, et al. Relationship of serum cytokines and severity of liver damage in patients with nonalcoholic steatohepatitis. Gastroenterology. 2001;120:A546.